analyzeportfolio
NYSE · Financials

GLOBE LIFE INC. (GL)

As-reported financials and SEC filings for GLOBE LIFE INC. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About GLOBE LIFE INC.

Globe Life Inc. provides life and health insurance products. The company offers various insurance policies to individuals and families. It serves customers primarily in the United States.

Snapshot

Revenue
$5.99B
Revenue growth (YoY)
3.7%
Net income
$1.16B
Diluted EPS
$14.07
Gross margin
Operating margin
Net margin
19.4%
FCF margin
20.9%
ROE
19.4%
net income / fiscal-year-end equity
P/E
11.5×
trailing when available, otherwise FY EPS
Market cap
$13.49B
Long-term debt / equity
0.39×
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Globe Life

  • Revenue grew 3.7% to $6.0B in FY2025, slower than the 6.1% the year before.
  • Most recent quarter Q2 FY2026: revenue $1.6B, up 8.0% from Q2 FY2025.
  • Free cash flow was $1.3B in FY2025, 20.9% of revenue.
  • Net income rose 8.4% to $1.2B in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Globe Life’s fundamentals sit among the 425 Financials companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Net margin19.4%
59th percentile of 377
FCF margin20.9%
55th percentile of 272
Revenue growth (YoY)+3.7%
27th percentile of 420
ROE19.4%
84th percentile of 375
P/E11.5×
36th percentile of 318
Long-term debt / equity0.39×
52nd percentile of 194
Short interest3.22d
36th percentile of 420

No reported insider purchases (code P) in the last 90 days; 27 insider sales totaling $34.5M. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 2 of the superinvestors we track (plus 5 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
2
+5 quant / multi-strat
Initiated / added
6
0 new, 6 added
Reduced / exited
4
1 trimmed, 3 exited
Combined position
$439.1M
reported long value
InvestorAs ofPosition valueSharesChange
AQR Capital ManagementquantQ2 2026$270.9M1.5MAdded
Two Sigma InvestmentsquantQ2 2026$55.1M308.3KAdded
Gotham Asset ManagementQ2 2026$45.3M253.3KAdded
Millennium ManagementquantQ2 2026$33.0M184.8KAdded
Citadel AdvisorsquantQ2 2026$22.4M125.1KReduced
Bridgewater AssociatesQ2 2026$11.8M66.1KAdded
D. E. ShawquantQ2 2026$644,1413.6KAdded

No longer held by: Maverick Capital (as of Q2 2026), Point72 Asset Management (as of Q2 2026), Soros Fund Management (as of Q2 2026)

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
0
code P
Bought (90d)
code P value
Sells (90d)
27
$34.5M
Reported activity
Net selling
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-08-07
filed 2026-08-10
MITCHELL ROBERT BRIANEVP, General Counsel and CROSell11.5K$182.77$2.1M
2026-08-07
filed 2026-08-10
MITCHELL ROBERT BRIANEVP, General Counsel and CROSell10.5K$183.83$1.9M
2026-08-07
filed 2026-08-10
MITCHELL ROBERT BRIANEVP, General Counsel and CROSell1.0K$184.75$188K
2026-07-31
filed 2026-08-03
Darden James MatthewCo-Chairman & CEOSell49.6K$182.43$9.0M
2026-07-31
filed 2026-08-03
Darden James MatthewCo-Chairman & CEOSell400$183.36$73K
2026-07-30
Kalmbach Thomas PeterEVP & CFOSell10.7K$179.30$1.9M
2026-07-30
Kalmbach Thomas PeterEVP & CFOSell4.8K$180.08$872K
2026-07-30
Kalmbach Thomas PeterEVP & CFOSell2.8K$181.81$507K
2026-07-30
Kalmbach Thomas PeterEVP & CFOSell2.6K$181.23$480K
2026-07-29
filed 2026-07-30
MAJORS MICHAEL CLAYEVP - Chief Strategy OfficerSell33.5K$178.56$6.0M
2026-07-29
filed 2026-07-30
MAJORS MICHAEL CLAYEVP - Chief Strategy OfficerSell3.5K$179.35$628K
2026-07-28
filed 2026-07-29
Kalmbach Thomas PeterEVP & CFOSell12.3K$178.73$2.2M

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
1.8M
settled 2026-08-14
Change vs prior
+9.8%
vs previous settlement
Days to cover
3.22
at avg daily volume
Avg daily volume
557.8K
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-141.8M+9.8%3.22
2026-07-311.6M-9.2%2.05
2026-07-151.8M+8.8%3.18
2026-06-301.7M-10.3%2.00
2026-06-151.8M+6.0%3.53
2026-05-291.7M+7.7%2.89
2026-05-151.6M-0.2%2.95
2026-04-301.6M+9.8%2.88

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$5.99B$5.78B$5.45B$5.23B$5.11B
Gross profit
Operating income$1.27B$1.19B$1.23B
Net income$1.16B$1.07B$970.8M$894.4M$1.03B
Diluted EPS$14.07$11.94$10.07$9.04$9.99

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

 FY2025FY2024FY2023FY2022FY2021
Cash and equivalents$144.7M$165.3M$103.2M$92.6M$92.2M
Current assets
Total assets$30.81B$29.08B$28.05B$25.99B$29.77B
Current liabilities
Long-term debt$2.32B$2.32B$1.63B$1.63B$1.55B
Total liabilities$24.84B$23.77B$23.56B$22.04B$21.13B
Total equity$5.97B$5.31B$4.49B$3.95B$2.00B

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$1.40B$1.40B$1.48B$1.42B$1.44B
Capital expenditure$142.5M$71.0M$49.6M$27.9M$38.2M
Free cash flow$1.25B$1.33B$1.43B$1.39B$1.40B

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$1.60B8.0%$287.7M$3.65
Q1 FY2026$1.56B5.3%$270.5M$3.39
Q4 FY2025$1.52B3.6%$266.1M$3.29
Q3 FY2025$1.51B4.0%$387.8M$4.73
Q2 FY2025$1.48B2.8%$252.7M$3.05
Q1 FY2025$1.48B4.5%$254.6M$3.01
Q4 FY2024$1.47B3.6%$255.2M$3.01
Q3 FY2024$1.46B5.2%$303.0M$3.44

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNYSE
SectorFinancials
SIC industryLife Insurance
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ2 FY2026 (ended June 30, 2026)
Oldest indexed filing2018
SEC CIK320335

Selected SEC filings

10-Q2026-08-05
View on EDGAR →
10-Q2026-05-07
View on EDGAR →
8-K2026-08-07
View on EDGAR →
8-K2026-07-22
View on EDGAR →
8-K2026-06-29
View on EDGAR →
8-K2026-05-04
View on EDGAR →

Largest Financials peers

All Financials companies →

Monitor GL

Get an alert when Globe Life files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor GL free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.